King Faisal Specialist Hospital and Research Centre (KFSHRC) in Riyadh has successfully implemented an advanced interventional technique to diagnose breast tumors that are undetectable by conventional imaging, enabling physicians to obtain precise biopsy samples during the same visit, thereby accelerating diagnosis and allowing for earlier treatment initiation.
This diagnostic shift addresses cases recorded in recent years where certain breast abnormalities could only be identified using contrast-enhanced imaging, prompting the hospital to adopt CEM as a precise clinical tool to overcome such diagnostic challenges.
Previously, the standard protocol required scheduling a separate MRI-guided biopsy following initial imaging—often resulting in redundant procedures, elevated patient burden, increased healthcare costs, and delayed treatment initiation. In contrast, the new CEM-guided approach allows for immediate and accurate tissue sampling during the same imaging session, eliminating the need for additional appointments.
KFSHRC brings substantial expertise to this advanced modality, having been the first to introduce contrast-enhanced mammography in the Kingdom nearly a decade ago. It remains among a select group of healthcare centers in the Middle East that routinely utilize this technique in clinical settings, reinforcing its diagnostic ecosystem and accelerating treatment decisions with enhanced precision.
It is noteworthy that KFSHRC has been ranked first in the Middle East and Africa and 15th globally in the list of the world’s top 250 Academic Medical Centres for the second consecutive year and has been recognized as the most valuable healthcare brand in the Kingdom and the Middle East, according to the 2024 Brand Finance rankings. Additionally, in the same year, it was ranked among the world's best 250 hospitals and included in the World’s Best Smart Hospitals list for 2025 by Newsweek magazine.
For more information, visit www.kfshrc.edu.sa or contact our media team at mediacoverage@kfshrc.edu.sa